|
|
|
Volumn 17, Issue 9 Suppl 8, 2003, Pages 32-36
|
|
Irinotecan in esophageal cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
CISPLATIN;
DRUG DERIVATIVE;
IRINOTECAN;
ADJUVANT THERAPY;
ARTICLE;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
ESOPHAGUS TUMOR;
HUMAN;
PATHOLOGY;
PHASE 1 CLINICAL TRIAL;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CISPLATIN;
DRUG ADMINISTRATION SCHEDULE;
ESOPHAGEAL NEOPLASMS;
HUMANS;
RADIOTHERAPY, ADJUVANT;
TREATMENT OUTCOME;
|
|
EID: 1542570574
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (9)
|
|
References (0)
|
